---
title: "JD.com’s Aggressive Pricing Reshapes Market as Baidu Doubles Down on AI Bets"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/302401318.md"
description: "JD.com's pricing clash with Tuhu reshaped auto aftermarket dynamics in September 2026, while Baidu rallied on AI optimism and NetEase capitalized on renewed game approvals. MedBot advanced healthcare AI deployments, and Senglong Semiconductor saw chip demand surge, reflecting sector's divergent paths."
datetime: "2026-10-20T10:15:34.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/302401318.md)
  - [en](https://longbridge.com/en/news/302401318.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/302401318.md)
generator: "portal-rs"
---

# JD.com’s Aggressive Pricing Reshapes Market as Baidu Doubles Down on AI Bets

JD.com (9618.HK) ignited a pricing war with Tuhu in late September 2026, disrupting the auto aftermarket and delaying Tuhu’s IPO. The move underscores e-commerce giants’ relentless push into offline services, though sustainability remains questionable.

Baidu (9888.HK) and its US-listed shares (BIDU.US) rode AI optimism as Hong Kong investors warmed to Ernie Bot 4.5’s enterprise applications. Cloud revenue now accounts for over 25% of total, yet Apollo’s path to profitability stays hazy.

NetEase (9999.HK) seized momentum from September’s game license approvals, with \*Justice Online\*’s global launch driving growth. But regulatory uncertainties linger as China refines its gaming framework.

MedBot (2158.HK) deployed AI-driven hospital management systems across 200 facilities, though monetization hurdles persist. Senglong Semiconductor (3661.HK) reported 20% Q2 revenue growth from AI chip demand but faces cyclical headwinds.

China Biopharm (1177.HK) partnered with Alibaba Health in May to integrate R&D and distribution, yet drug pricing pressures remain acute. Viva Biotech (1873.HK) accelerated drug discovery via AI, though international client growth slowed.

Dongpeng Drinks (9980.HK), an outlier in this tech cohort, leveraged JD Daojia for 30% online sales growth—proof that digital transformation permeates even traditional sectors. Swisher-style take: While pricing battles grab headlines, real innovation hides in quarterly footnotes.

### Related Stocks

- [BIDU.US](https://longbridge.com/en/quote/BIDU.US.md)
- [09888.HK](https://longbridge.com/en/quote/09888.HK.md)
- [03661.HK](https://longbridge.com/en/quote/03661.HK.md)
- [01177.HK](https://longbridge.com/en/quote/01177.HK.md)
- [02158.HK](https://longbridge.com/en/quote/02158.HK.md)
- [01873.HK](https://longbridge.com/en/quote/01873.HK.md)
- [09999.HK](https://longbridge.com/en/quote/09999.HK.md)
- [09980.HK](https://longbridge.com/en/quote/09980.HK.md)
- [09618.HK](https://longbridge.com/en/quote/09618.HK.md)

## Related News & Research

- [JD.com Q3 2026 Earnings Preview](https://longbridge.com/en/news/305704165.md)
- [JD.com Analysts Slash Their Forecasts Following Weak Q3 Results](https://longbridge.com/en/news/305983643.md)
- [JD.com (JD) Could Be 29% Undervalued After Margin Focus And AI Gains](https://longbridge.com/en/news/305764012.md)
- [NetEase discloses share repurchase in HKEX next-day return](https://longbridge.com/en/news/306242019.md)
- [JPM Notes NTES 3Q Online Gaming Revenue Misses, Foresees Short-term Share Price Volatility](https://longbridge.com/en/news/306211532.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**